Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 1126 AL 1140

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

del Campo M, Mollenhauer B, Bertolotto A, Engelborghs S, Hampel H, Simonsen AH, Kapaki E, Kruse N, Le Bastard N, Lehmann S, Molinuevo JL, Parnetti L, Perret-Liaudet A, Sáez-Valero J, Saka E, Urbani A, Vanmechelen E, Verbeek M, Visser PJ, Teunissen C.

Biomark Med. 2012 Aug;6(4):419-30. doi: 10.2217/bmm.12.46.

Atypical motor and behavioral presentations of Alzheimer disease: a case-based approach

Duker AP, Espay AJ, Wszolek ZK, Rademakers R, Dickson DW, Kelley BJ.

Neurologist. 2012 Sep;18(5):266-72. doi: 10.1097/NRL.0b013e3182675376.

Neuropsychological assessment of driving safety risk in older adults with and without neurologic disease

Anderson SW, Aksan N, Dawson JD, Uc EY, Johnson AM, Rizzo M.

J Clin Exp Neuropsychol. 2012;34(9):895-905. doi: 10.1080/13803395.2011.630654. Epub 2012 Sep 3.

Inflammation and neurodegeneration: the story 'retolled'

Drouin-Ouellet J, Cicchetti F.

Trends Pharmacol Sci. 2012 Oct;33(10):542-51. doi: 10.1016/j.tips.2012.07.002. Epub 2012 Aug 31.

Target-based selection of flavonoids for neurodegenerative disorders

Jones QR, Warford J, Rupasinghe HP, Robertson GS.

Trends Pharmacol Sci. 2012 Nov;33(11):602-10. doi: 10.1016/j.tips.2012.08.002. Epub 2012 Sep 12.

Pharmacological treatment of dementia

Schwarz S, Froelich L, Burns A.

Curr Opin Psychiatry. 2012 Nov;25(6):542-50. doi: 10.1097/YCO.0b013e328358e4f2.

[Ceruloplasmin (Cp) and iron in connection with Parkinson's disease (PD) and Alzheimer's disease (AD)]

Johannesson T, Kristinsson J, Torsdottir G, Snaedal J.

Laeknabladid. 2012 Oct;98(10):531-7. doi: 10.17992/lbl.2012.10.457.

A novel PSEN1 H163P mutation in a patient with early-onset Alzheimer's disease: clinical, neuroimaging, and neuropathological findings

Kim J, Bagyinszky E, Chang YH, Choe G, Choi BO, An SS, Kim S.

Neurosci Lett. 2012 Nov 21;530(2):109-14. doi: 10.1016/j.neulet.2012.09.040. Epub 2012 Oct 6.

Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome

Cárdenas AM, Ardiles AO, Barraza N, Baéz-Matus X, Caviedes P.

Arch Med Res. 2012 Nov;43(8):645-54. doi: 10.1016/j.arcmed.2012.10.012. Epub 2012 Nov 7.

Caregiver burden in Parkinson disease with dementia compared to Alzheimer disease in Korea

Shin H, Youn J, Kim JS, Lee JY, Cho JW.

J Geriatr Psychiatry Neurol. 2012 Dec;25(4):222-6. doi: 10.1177/0891988712464819. Epub 2012 Nov 21.

Different approaches, one target: understanding cellular mechanisms of Parkinson's and Alzheimer's diseases

Torrão AS, Café-Mendes CC, Real CC, Hernandes MS, Ferreira AF, Santos TO, Chaves-Kirsten GP, Mazucanti CH, Ferro ES, Scavone C, Britto LR.

Braz J Psychiatry. 2012 Oct;34 Suppl 2:S194-205. doi: 10.1016/j.rbp.2012.08.004.

Frontotemporal dementia: implications for understanding Alzheimer disease

Goedert M, Ghetti B, Spillantini MG.

Cold Spring Harb Perspect Med. 2012 Feb;2(2):a006254. doi: 10.1101/cshperspect.a006254.

Sunlight exposure is important for preventing hip fractures in patients with Alzheimer's disease, Parkinson's disease, or stroke

Iwamoto J, Takeda T, Matsumoto H.

Acta Neurol Scand. 2012 Apr;125(4):279-84. doi: 10.1111/j.1600-0404.2011.01555.x. Epub 2011 Jun 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias